While the brain acquires resistance to continuous treatment with mGluR5 inhibitor drugs, lasting effects may still arise if dosing occurs intermittently and during a developmental-critical period.

Study suggests a common mechanism underlies some behavioral traits seen in autism and schizophrenia.

New analysis could help uncover potential drug targets for attention deficits and sensory hypersensitivity.

Among study’s many surprises may be a new way to address Fragile X syndrome — by finding a “protein X.”

Drug compound, tested in mice, could be effective in treating the leading heritable cause of intellectual disability and autism.

A new study may explain why people with autism are often highly sensitive to light and noise.

An immune molecule sometimes produced during infection can influence the social behavior of mice.

Findings in mice suggest targeting certain brain circuits could offer new ways to treat some neurological disorders.

In a mouse model, restoring activity of a specific forebrain region reverses social traits associated with autism.

By introducing a gene variant associated with autism into monkeys, researchers hope to study treatment options for severe neurodevelopmental disorders.